CNSP financials
CNS Pharmaceuticals (CNSP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
CNSP income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$15.99M | -$15.85M | -1072.50 |
| 2024 | – | – | -$14.90M | -$14.86M | -14006.70 |
| 2023 | – | – | -$18.87M | -$18.85M | -4507575.36 |
| 2022 | – | – | -$15.27M | -$15.27M | -10107558.22 |
| 2021 | – | – | -$14.49M | -$14.50M | -14864056.21 |
| 2020 | – | – | -$9.45M | -$9.46M | -513485.58 |